Discover
Visualize rapid, validated insights through real-world data.
Research Spotlight: A Deep Dive into a Real-World Reproducibility Study
Both real-world data (RWD) and real-world evidence (RWE) studies continue to effectively ...
Partnering to enhance Japanese RWD at a global scale: A Q&A with JMDC
JMDC, a leading Japanese health big data firm, and Aetion® recently announced a ...
Research Spotlight: Navigating Treatment Effectiveness in Rare Oncology with External Control Cohorts
Real-world data (RWD) has proven to be a pivotal tool in understanding patient treatment ...
What I saw at DIA RWE 2023
I am just back from Baltimore, Maryland, where I had the joy of attending DIA’s ...
Advancing RWE in Oncology with Aetion’s CARE Initiative
In late 2022, Aetion announced the launch of the Aetion Coalition to Advance Real‐World ...
What I saw at ICPE 2023
I just had the pleasure and privilege of attending the 39th International Conference on ...
Leveraging the SURF screening tool to understand how to identify whether RWE of effectiveness may be acceptable for regulatory decision-making for a clinical development program
Ulka Campbell, Ph.D., is Aetion’s Head of Scientific Strategy. In this role, she uses her ...
The Inflation Reduction Act Puts Real-World Evidence Front and Center
The drug price negotiation provisions of the Inflation Reduction Act (IRA) will ...
Implementation of synthetic data generation in the enterprise
By Khaled El Emam | Published: April, 2023 The following article was published by ...
Aetion submits comments to FDA on recent draft guidance on considerations for externally controlled trials
Earlier this week, Aetion submitted a letter to FDA commenting on the Agency’s recent ...
Setting Real-World Standards at ISPOR 2023
Aetion joins other industry experts at ISPOR 2023 to discuss standard-setting and ...
Scientist spotlight: A deeper dive on RCT-DUPLICATE
This week, the final results of the RCT-DUPLICATE (RCT-D) study were published in the ...
Privacy Assurance FAQ
What is Privacy Assurance? One of the benefits of synthetic data is that it has low ...
Synthetic Data Generation FAQ
What is synthetic data generation (SDG)? There are many ways to generate synthetic data. ...
Aetion® Generate FAQ
What is Generate? Aetion® Generate, formerly Replica Synthesis, is Aetion’s scalable ...
Research spotlight: RWD transferability across borders
Manufacturers are increasingly using real-world data (RWD) to generate real-world ...
A Solution for Payers to Use Real World Evidence in Pharma Confidently
Tackling three common concerns
RWE Meaning | Update: What the Omnibus FDA Amendments Mean for RWE
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023, a ...
Replica Analytics Top 10 Round-up for 2022
By Replica staff
Validating a Membership Disclosure Metric for Synthetic Health Data
By Lucy Mosquera | Posted On: October 11, 2022 We have just had a paper published in ...
RWE guidance watch: EUnetHTA’s Direct and Indirect Comparisons guidance
The European Network for Health Technology Assessment (EUnetHTA) recently published two ...
Aetion’s best practices referenced in ENCePP’s updated Guide on Methodological Standards in Pharmacoepidemiology
On July 1, 2022, the European Network of Centres for Pharmacoepidemiology and ...
New estimator uses synthetic data generation for more reliable evaluation of re-identification risk in datasets
By Lucy Mosquera and Abhik Das
Why work at a startup? Because everything you do matters
Several years ago, during a hiring interview for a software engineer position, the ...